Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.
about
Optimal delivery of follow-up care after surgery for Crohn's disease: current perspectivesCurrent approaches for optimizing the benefit of biologic therapy in ulcerative colitisPredicting durable response or resistance to antitumor necrosis factor therapy in inflammatory bowel diseaseCognitive behavioural therapy for the management of inflammatory bowel disease-fatigue with a nested qualitative element: study protocol for a randomised controlled trial.Patient Reported Outcome Measures (PROMs) in Inflammatory Bowel Disease: New Data.A Proposal for a Study on Treatment Selection and Lifestyle Recommendations in Chronic Inflammatory Diseases: A Danish Multidisciplinary Collaboration on Prognostic Factors and Personalised Medicine.Elevated C-reactive protein level during clinical remission can predict poor outcomes in patients with Crohn's disease.The Impact of Clinical Information on the Assessment of Endoscopic Activity: Characteristics of the Ulcerative Colitis Endoscopic Index Of Severity [UCEIS].The Impact of Magnetic Resonance Enterography and Capsule Endoscopy on the Re-classification of Disease in Patients with Known Crohn's Disease: A Prospective Israeli IBD Research Nucleus (IIRN) Study.The Utility of Fecal Calprotectin in the Real-World Clinical Care of Patients with Inflammatory Bowel Disease.Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases.Effects of vedolizumab on health-related quality of life in patients with ulcerative colitis: results from the randomised GEMINI 1 trialIdentification of Pathway-Specific Serum Biomarkers of Response to Glucocorticoid and Infliximab Treatment in Children with Inflammatory Bowel Disease.Simple pain measures reveal psycho-social pathology in patients with Crohn's disease.Second Korean guidelines for the management of Crohn's disease.Dynamic Contrast-Enhanced Magnetic Resonance Enterography and Dynamic Contrast-Enhanced Ultrasonography in Crohn's Disease: An Observational Comparison Study.Compliance with the faecal calprotectin test in patients with inflammatory bowel disease.Monitoring of small bowel Crohn's disease.Current and Future Targets for Mucosal Healing in Inflammatory Bowel Disease.Development of a core outcome set for clinical trials in inflammatory bowel disease: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.Disease activity and mucosal healing in inflammatory bowel disease: a new role for histopathology?Preventing Collateral Damage in Crohn's Disease: The Lémann Index.Understanding Endoscopic Disease Activity in IBD: How to Incorporate It into Practice.Examining maintenance care following infliximab salvage therapy for acute severe ulcerative colitis.Pharmacokinetic drug evaluation of budesonide in the treatment of Crohn's disease.The safety of non-biological treatments in Ulcerative Colitis.Management of Inflammatory Bowel Disease in the Elderly Patient: Challenges and Opportunities.Immunomodulators for the treatment of Crohn's disease in adults: optimal use and prospects for future drug treatments.Review article: moving towards common therapeutic goals in Crohn's disease and rheumatoid arthritis.Clinical Utility of Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease: A Systematic Review and Practical Guide.Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease.Anti TNF-α therapy for ulcerative colitis: current status and prospects for the future.Practical Approaches to "Top-Down" Therapies for Crohn's Disease.Therapeutic Drug Monitoring of Golimumab in the Treatment of Ulcerative Colitis.Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials.Computed Tomography and Magnetic Resonance Enterography in Crohn's Disease: Assessment of Radiologic Criteria and Endpoints for Clinical Practice and Trials.Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn's disease and ulcerative colitis.Responsiveness of Endoscopic Indices of Disease Activity for Crohn's Disease.The Importance and Challenges of Dietary Intervention Trials for Inflammatory Bowel Disease.Treat to Target in Inflammatory Bowel Disease: An Updated Review of Literature.
P2860
Q26740356-120FEBED-A8D3-481E-AD9B-226C29F7BB91Q26745712-28ECD5CA-02BD-4FEB-9DD8-5972BD39E235Q26745721-4727EF20-ECA5-4CEC-AD47-58EC2FB054E3Q29994702-392C04B4-B97E-4B9C-9FDC-64C74B6BD980Q31140142-3495297E-BE24-4E91-87AA-6BCE726D96F4Q33749513-3DE19AA0-9C76-4783-9966-1AE910AE2CB2Q33806908-C4570186-8FAA-467F-80F7-29295914E878Q35625694-6F0318FF-8CBF-4262-8E27-12DD0790E723Q37118410-E296BA9D-08CC-4539-9D24-B227CBB4A1F9Q37329989-74138EF6-2096-4C05-AF09-8CAC782486A6Q37521805-D5C854E3-C637-43E3-8937-D565A37F2E3AQ37561775-7598D453-5028-4D40-A133-163FB4C622A9Q37620348-2B672DBB-9FDC-4405-BDA1-85B94448E7A5Q37643997-5240914B-52EB-465C-B870-E3B897AE24EDQ37662498-2999FBBB-4478-47E5-8E11-2BC2D8A86E66Q37684706-77D8AC49-B757-49DE-AA20-B28590B0B890Q38641380-C42C4568-84C8-4759-B7B8-2D4E9994A03EQ38652740-C5F2F7D6-5834-443E-B3F6-70ADDAC4C3EDQ38671272-93EC4F37-AC8A-49F5-870B-989744BCA8CBQ38672414-A196EB5D-09E0-493F-93A4-1E8C3B676F6AQ38677581-2B48C0E2-2C94-498A-A7E5-4607488828D6Q38690180-2875FD82-04E6-424B-AAD3-C035DDB621F9Q38694153-92B0682A-15FE-41E4-BAC4-3F827F4A112FQ38724227-186CF78B-32A6-4148-9E34-8BE3FDCAE616Q38726458-3B0894F1-2E48-4CA4-83CC-E4BEF7BB92D7Q38728164-9A378CBC-C797-414E-BADD-65058FA9D5C0Q38735146-DC1EBBC8-92AC-44FF-9500-5D127EDCA9FEQ38743666-292EA607-DF30-46FE-BB7F-C77F961C1954Q38752119-F521F817-2296-4FDA-98AF-D27CD26E8678Q38782416-AEDFC40D-98F1-4424-86CF-FC44687DD2FEQ38797791-4FD5AB1A-4DC5-4F0C-B90F-AD7E284243AEQ38816194-F05DBFC6-F1A6-4921-976B-9029574446FDQ38835478-53B39876-D3D1-47CF-9FEF-554BBE38E36FQ38856947-CF3A0CBA-A2E9-4ABD-827A-77E2438DECFBQ38888227-4099B557-E645-4736-B4D1-5EAB4F6F4C51Q38923621-99BB71D6-0098-4997-8523-1912468C6D49Q39012932-CA74059A-886E-4E05-AE46-CDC6E246233EQ39029702-7B1CC540-9464-4F9B-89F4-C3ABD50D54EAQ39082805-1B25A4A5-5322-41E2-B1C2-4881336064A8Q39120033-AAA0B3B5-35B5-4A19-B313-457C33C888B3
P2860
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Selecting Therapeutic Targets ...... tic Goals for Treat-to-Target.
@en
type
label
Selecting Therapeutic Targets ...... tic Goals for Treat-to-Target.
@en
prefLabel
Selecting Therapeutic Targets ...... tic Goals for Treat-to-Target.
@en
P2093
P50
P356
P1476
Selecting Therapeutic Targets ...... utic Goals for Treat-to-Target
@en
P2093
C A Siegel
G Van Assche
P304
P356
10.1038/AJG.2015.233
P407
P50
P577
2015-08-25T00:00:00Z